Nav: Home

Pulmonary arterial hypertension medical management of the adult patient with CHD

June 10, 2018

Pulmonary Arterial Hypertension Medical Management of the Adult Patient with Congenital Heart Disease

In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 1, 2018, pp. pp. 1-8(8); DOI 10.15212/CVIA.2017.0038), Ali Ataya, Julian Chung, Jessica Cope and Hassan Alnuaimat from Division of Pulmonary, Critical Care and Sleep Medicine, and Department of Pharmacy, University of Florida, Gainesville, FL, USA consider how congenital heart disease (CHD)-associated pulmonary arterial hypertension (PAH) includes a heterogeneous patient population that can be characterized by the underlying cardiac malformation.

CHD-associated PAH has an estimated prevalence of 5-10% in adult patients, with an increasing number of patients surviving to adulthood because of advances in the surgical management and the development of pulmonary arterial hypertension (PAH)-targeted pharmacotherapy. Although limited data exist, targeted PAH pharmacotherapy has proven to be beneficial in patients with CHD-associated PAH, with observed improvement in functional class, increase in exercise capacity, and improvement in quality of life and cardiopulmonary hemodynamics. Additionally, there has been increasing interest in the "treat-to-close" strategy. PAH-targeted pharmacotherapy may be used to optimize cardiopulmonary hemodynamics so as to improve patients' operability in repairing the cardiac defect. Although there have been significant advances in the management of this disease state in the past 2 decades, mortality remains high, and ongoing clinical trials are needed to better understand the treat-to-close strategy.
-end-
CVIA is available on the IngentaConnect platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. CVIA is indexed in the ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information)

Cardiovascular Innovations and Applications

Related Congenital Heart Disease Articles:

Genes responsible for severe congenital heart disease identified by Pitt researcher
Genes responsible for hypoplastic left heart syndrome identified using mouse models.
Ablation for atrial fibrillation proven safe and effective for patients with congenital heart disease, Penn study finds
In a new study presented today at the Heart Rhythm Society's 38th Annual Scientific Session in Chicago, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that CHD patients -- even with complex defects -- can safely undergo ablation for AF, with similar success rates as patients with normal hearts.
Lessening radiation risk for children with congenital and acquired heart disease
Newly released recommendations for pediatric radiation safety will be discussed during the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans.
High-throughput, in vivo validation of candidate congenital heart disease genes
Specific genetic errors that trigger congenital heart disease in humans can be reproduced reliably in Drosophila melanogaster -- the common fruit fly -- an initial step toward personalized therapies for patients in the future.
Women with high-risk congenital heart disease can have successful pregnancies
Women with high-risk congenital heart disease can have successful pregnancies but should seek counseling before conception to understand how their conditions could affect pregnancy and their child's health.
First US babies treated in study of adult stem cell therapy for congenital heart disease
In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS).
Children dying preventable deaths from congenital heart disease
Over one million children are born with congenital heart disease (CHD) each year, and 90 percent are born in poor regions with little or no access to care.
Einstein scientist receives $7.5 million grant for congenital heart disease research
The National Institutes of Health has awarded Bernice Morrow, Ph.D., at Albert Einstein College of Medicine and collaborators at the Children's Hospital of Philadelphia a five-year, $7.5 million grant to study the genetics of congenital heart abnormalities.
Mother's blood sugar measurement associated with baby's congenital heart disease risk
For the first time, researchers have shown that the level of blood sugar measured in the first trimester of pregnancy may be associated with the risk of delivering a baby with congenital heart disease, according to a preliminary study presented at the American Heart Association's Scientific Sessions 2016.
Women with congenital heart disease have better shot at healthy pregnancies
New research from the Perelman School of Medicine at the University of Pennsylvania reveals that women with CHD who are deemed high risk by conventional measures are more likely to have safe, healthy pregnancies than current risk-assessments suggest.

Related Congenital Heart Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...